A Comprehensive Analysis of Auditory Event-related Potentials and Network Oscillations in an NMDA Receptor Antagonist Mouse Model Using a Novel Wireless Recording Technology

Overview

Journal Physiol Rep

Specialty Physiology

Date 2018 Aug 30

PMID 30155997

Citations 22

Authors

Niklas Schuelert

Cornelia Dorner-Ciossek

Michael Brendel

Holger Rosenbrock

Affiliations

Soon will be listed here.

Abstract

There is growing evidence that impaired sensory processing significantly contributes to cognitive deficits found in schizophrenia. Electroencephalography (EEG) has become an important preclinical and clinical technique to investigate the underlying mechanisms of neurophysiological dysfunctions in psychiatric disorders. Patients with schizophrenia show marked deficits in auditory event-related potentials (ERP), the detection of deviant auditory stimuli (mismatch negativity, MMN), the generation and synchronization of 40 Hz gamma oscillations in response to steady-state auditory stimulation (ASSR) and reduced auditory-evoked oscillation in the gamma range. Due to a novel data-logging technology (Neurologger, TSE Systems), it is now possible to record wireless EEG data in awake, free-moving small rodents without any restrictions due to size of the device or attached cables. Recently, a new version of the Neurologger was released with improved performance to record time-locked event-related EEG signals. In this study, we were able to show in mice that pharmacological intervention with the NMDA receptor antagonists Ketamine and MK-801 can impair a comprehensive selection of EEG/ERP readouts (ERP N1 amplitude, 40 Hz ASSR, basal and evoked gamma oscillation, MMN) and therefore mimic the EEG deficits observed in patients with schizophrenia. Our data support the translational value of NMDA receptor antagonists as a model for preclinical evaluation of sensory processing deficits relevant to schizophrenia. Further, the new Neurologger system is a suitable device for wireless recording of clinically relevant EEG biomarkers in freely moving mice and a robust translational tool to investigate novel therapeutic approaches regarding sensory processing deficits related to psychiatric disorders such as schizophrenia.

Citing Articles

Auditory evoked-potential abnormalities in a mouse model of 22q11.2 Deletion Syndrome and their interactions with hearing impairment.

Lu C, Linden J Transl Psychiatry. 2025; 15(1):4.

PMID: 39779687 PMC: 11711659. DOI: 10.1038/s41398-024-03218-x.

Discovery of VU6024578/BI02982816: An mGlu Positive Allosteric Modulator with Efficacy in Preclinical Antipsychotic and Cognition Models.

Reed C, Kalbfleisch J, Turkett J, Trombley T, Nastase A, Spearing P J Med Chem. 2024; 67(24):22291-22312.

PMID: 39665415 PMC: 11684029. DOI: 10.1021/acs.jmedchem.4c02554.

Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.

Javitt D Adv Neurobiol. 2024; 40:411-451.

PMID: 39562453 DOI: 10.1007/978-3-031-69491-2_15.

Gamma Oscillations as a Biomarker of Neural Circuit Function in Psychosis: Where Are We, and Where Do We Go from Here?.

Spencer K Adv Neurobiol. 2024; 40:321-349.

PMID: 39562450 DOI: 10.1007/978-3-031-69491-2_12.

Effects of N-Methyl-d-Aspartate Receptor Antagonists on Gamma-Band Activity During Auditory Stimulation Compared With Electro/Magneto-encephalographic Data in Schizophrenia and Early-Stage Psychosis: A Systematic Review and Perspective.

Bianciardi B, Mastek H, Franka M, Uhlhaas P Schizophr Bull. 2024; 50(5):1104-1116.

PMID: 38934800 PMC: 11349021. DOI: 10.1093/schbul/sbae090.

References

Rissling A, Light G . Neurophysiological measures of sensory registration, stimulus discrimination, and selection in schizophrenia patients. Curr Top Behav Neurosci. 2011; 4:283-309. DOI: 10.1007/7854_2010_59. View

Carlen M, Meletis K, Siegle J, Cardin J, Futai K, Vierling-Claassen D . A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry. 2011; 17(5):537-48. PMC: 3335079. DOI: 10.1038/mp.2011.31. View

Gandal M, Edgar J, Klook K, Siegel S . Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology. 2011; 62(3):1504-18. PMC: 3264822. DOI: 10.1016/j.neuropharm.2011.02.007. View

Moghaddam B, Adams B, Verma A, Daly D . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci. 1997; 17(8):2921-7. PMC: 6573099. View

Dawson N, Xiao X, McDonald M, Higham D, Morris B, Pratt J . Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks. Cereb Cortex. 2012; 24(2):452-64. DOI: 10.1093/cercor/bhs322. View

Adler L, Rose G, Freedman R . Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry. 1986; 21(8-9):787-98. DOI: 10.1016/0006-3223(86)90244-1. View

Herrmann C, Munk M, Engel A . Cognitive functions of gamma-band activity: memory match and utilization. Trends Cogn Sci. 2004; 8(8):347-55. DOI: 10.1016/j.tics.2004.06.006. View

Kirihara K, Rissling A, Swerdlow N, Braff D, Light G . Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biol Psychiatry. 2012; 71(10):873-80. PMC: 3434875. DOI: 10.1016/j.biopsych.2012.01.016. View

Neill J, Harte M, Haddad P, Lydall E, Dwyer D . Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans. Eur Neuropsychopharmacol. 2013; 24(5):822-35. DOI: 10.1016/j.euroneuro.2013.09.011. View

10.

Brenner C, Krishnan G, Vohs J, Ahn W, Hetrick W, Morzorati S . Steady state responses: electrophysiological assessment of sensory function in schizophrenia. Schizophr Bull. 2009; 35(6):1065-77. PMC: 2762626. DOI: 10.1093/schbul/sbp091. View

11.

Taaseh N, Yaron A, Nelken I . Stimulus-specific adaptation and deviance detection in the rat auditory cortex. PLoS One. 2011; 6(8):e23369. PMC: 3154435. DOI: 10.1371/journal.pone.0023369. View

12.

Hudson M, Rind G, OBrien T, Jones N . Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine. Transl Psychiatry. 2016; 6:e784. PMC: 4872409. DOI: 10.1038/tp.2016.51. View

13.

Razoux F, Garcia R, Lena I . Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology. 2006; 32(3):719-27. DOI: 10.1038/sj.npp.1301057. View

14.

Lee M, Sehatpour P, Hoptman M, Lakatos P, Dias E, Kantrowitz J . Neural mechanisms of mismatch negativity dysfunction in schizophrenia. Mol Psychiatry. 2017; 22(11):1585-1593. PMC: 5547016. DOI: 10.1038/mp.2017.3. View

15.

Oranje B, Gispen-de Wied C, Verbaten M, Kahn R . Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol. Biol Psychiatry. 2002; 52(9):887-95. DOI: 10.1016/s0006-3223(02)01377-x. View

16.

Kulikova S, Tolmacheva E, Anderson P, Gaudias J, Adams B, Zheng T . Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing. Eur J Neurosci. 2012; 36(10):3407-19. DOI: 10.1111/j.1460-9568.2012.08263.x. View

17.

Sullivan E, Timi P, Hong L, ODonnell P . Effects of NMDA and GABA-A Receptor Antagonism on Auditory Steady-State Synchronization in Awake Behaving Rats. Int J Neuropsychopharmacol. 2015; 18(7):pyu118. PMC: 4540097. DOI: 10.1093/ijnp/pyu118. View

18.

Uhlhaas P, Singer W . Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010; 11(2):100-13. DOI: 10.1038/nrn2774. View

19.

Phillips K, Cotel M, McCarthy A, Edgar D, Tricklebank M, ONeill M . Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia. Neuropharmacology. 2011; 62(3):1359-70. DOI: 10.1016/j.neuropharm.2011.04.006. View

20.

Kwon J, ODonnell B, Wallenstein G, Greene R, Hirayasu Y, Nestor P . Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry. 1999; 56(11):1001-5. PMC: 2863027. DOI: 10.1001/archpsyc.56.11.1001. View